Life Science Investing uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease 03 November
Life Science Investing uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares 29 September
Life Science Investing uniQure Announces Pricing of Upsized $300 Million Public Offering 26 September
